Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen represent the collective group of hydrophobic molecules and emulsifiers present in the gut during the digestive process (NCBI, 2023). Dietary lipids, primarily triglycerides, undergo emulsification by bile acids and enzymatic hydrolysis by pancreatic lipases to facilitate absorption into the intestinal mucosa (StatPearls, 2023). Cholesterol in the lumen originates from both dietary intake and biliary secretion, requiring incorporation into mixed micelles for transport to the enterocyte surface (PubMed, 2021). Bile acids are steroid acids synthesized from cholesterol in the liver that act as biological detergents to solubilize these fats and fat-soluble vitamins (StatPearls, 2023). Therapeutic strategies targeting these luminal components include bile acid sequestrants, which bind bile acids to prevent their reabsorption, thereby lowering systemic LDL cholesterol levels (Mayo Clinic, 2023). Additionally, lipase inhibitors like orlistat prevent the breakdown of dietary fats to reduce caloric intake for obesity management (FDA, 2023). Because this entry describes a physiological environment and multiple chemical classes rather than a single protein or receptor, it is categorized as a composite system rather than a discrete molecular target.
Bile acid sequestration to prevent enterohepatic circulation; Inhibition of gastric and pancreatic lipases to prevent triglyceride hydrolysis; Competitive displacement of cholesterol from mixed micelles.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary lipids, cholesterol, and bile acids in the gastrointestinal lumen.